Lumida
/TMDX
⌘K
Transmedics Group Inc

Transmedics Group Inc

TMDX
$82.18USD-3.36%-2.86 today

MARKET CAP

2.8B

P/E (TTM)

18.8x

FWD P/E

DAY RANGE

$79 – $86

52W RANGE

$60
$156

AI Summary

Stalk
Sell NowMedium

TMDX has broken below key moving averages and failed to sustain its recent advance, shifting the medium-term bias to bearish while the long-term trend remains negative under a declining 200DMA. Short-term momentum confirms the downside as price rejects EMAs and RSI turns down. Execution favors selling on rallies into the former support-turned-resistance zone.

  • Q2 revenue of $190 M grew 21% YoY, led by 29% service revenue growth
  • Full-year 2026 revenue guidance increased 22–25% YoY to $737–757 M
  • EPS down 52% YoY amid rising operating expenses
Full analysis →

Buying

6

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY5.60 M371.72 M+303.22 K-29.4%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY1.42 M94.13 M+1.19 M+314.2%0.01%
MM

Millennium Management LLC

Q2 2026

SELL263.01 K17.47 M+-48.87 K-43.6%0.01%
JH

Janus Henderson Group Plc

Q1 2026

BUY146.98 K14.61 M+75.03 K+66.9%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY211.79 K14.07 M+199.49 K+1050.5%0.02%
JC

Jpmorgan Chase & Co

Q2 2026

SELL192.27 K13.04 M+-116.07 K-55.2%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW28.81 K1.91 M+28.81 K+0.0%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUY27.95 K1.86 M+20.17 K+140.0%0.00%
MG

Man Group Plc

Q2 2026

SELL11.33 K752.34 K+-147.08 K-95.2%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL1.55 K103.15 K+-229.00-41.8%0.00%
HS

Hussman Strategic Advisors, Inc.

Q2 2026

SELL0.000.00+-31.50 K-100.0%0.00%